Energy News / AllPennyStocks.com Media, Inc.

AllPennyStocks.com News: Bee Vectoring Busy After FDA Exemption

Via: ReleaseWire

Updated 11:54 AM CDT, Wed, October 30,2019

Mississauga, ON -- (SBWIRE) -- 10/30/2019 -- AllPennyStocks.com Media, Inc. (https://www.AllPennyStocks.com/) announces its latest article titled "Bee Vectoring Busy After FDA Exemption."

Companies mentioned in this article include Bee Vectoring Technologies International (TSX-Venture:BEE).

Article Excerpt:

Companies trying to get their products to market need to withstand the scrutiny of various government agencies on both sides of the border. When they can either sidestep or win exemptions from restrictions, the result is a big boost to their profile, and their stock prices.

The beneficiary of one of these exemption is Mississauga, Ontario-based Bee Vectoring Technologies International (TSX-Venture:BEE). The company, with offices in Sacramento, Calif., told investors Wednesday that the U.S. Environmental Protection Agency (EPA) has established such an exemption from the requirement of a tolerance under the Federal Food, Drug and Cosmetic Act (FFDCA) for Clonostachys rosea Strain CR-7, BVT's proprietary beneficial microbe, and the active ingredient in its recently EPA-registered product, VECTORITEâ„¢ with CR7.

The full version of this article can be found at:
https://www.allpennystocks.com/specialreportsca/1231/bee-vectoring-busy-after-fda-exemption

About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: https://www.allpennystocks.com/newsletter.

Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: https://www.allpennystocks.com / http://www.bullishinvestor.com

Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: https://www.allpennystocks.com/disclaimer.

For more information on this press release visit:
http://www.sbwire.com/press-releases/allpennystockscom-news-bee-vectoring-busy-after-fda-exemption-1263760.htm

Media Relations Contact
Peter Szafranski
1-905-361-5680
Email: Click to Email Peter Szafranski
Web: http://www.allpennystocks.com